
Opinion|Videos|March 28, 2024
Integrating CGMs into Diabetes Treatment Programs
Payer perspectives on the challenges and advantages of integrating continuous glucose monitoring into diabetes management programs, highlighting the navigation of prior authorization requirements.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
1,700 sites closed, 77,000 fewer children received PEPFAR-supported treatment after PEPFAR disruption | IAS 2026
2
Payers lean on step therapy, formulary exclusions as IRA reshapes Part D benefit design
3
Redemplo cuts triglycerides, pancreatitis risk in severe hypertriglyceridemia
4
Step therapy requirements drive up time, costs in DME patients | ASRS 2026
5





























